ACADIA Pharmaceuticals Inc (ACAD) — Free Cash Flow Generation Index
ACADIA Pharmaceuticals Inc (ACAD) has a Free Cash Flow Generation Index of 0.85x as of March 2026. Free cash flow of $28.77 Million represents 1% of operating cash flow ($33.98 Million). See ACADIA Pharmaceuticals Inc (ACAD) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ACADIA Pharmaceuticals Inc Free Cash Flow Generation Index (2023–2025)
Historical FCF Generation Index trend for ACADIA Pharmaceuticals Inc across 3 annual periods. Explore cash flow to debt ratio of ACADIA Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for ACADIA Pharmaceuticals Inc (2023–2025)
Year-by-year Free Cash Flow Generation Index for ACADIA Pharmaceuticals Inc. For the full company profile including market capitalisation, see ACADIA Pharmaceuticals Inc market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | $105.15 Million | $109.84 Million | $4.69 Million | ▼ -4.0% |
| 2024 | 1.00x | $157.20 Million | $157.72 Million | $523.00K | ▲ +171.3% |
| 2023 | -1.40x | $-23.35 Million | $16.70 Million | $40.05 Million | — |